S-8 1 tm2114482d1_s8.htm FORM S-8

As filed with the Securities and Exchange Commission on May 5, 2021

Registration No. 333-  

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

SILICON LABORATORIES INC.

(Exact name of registrant as specified in its charter)

 

Delaware       74-2793174  
     
(State or other jurisdiction of       (I.R.S Employer Identification No.)  
     
incorporation or organization)          

 

400 West Cesar Chavez

Austin, Texas 78701

(Address, including zip code, of registrant’s principal executive offices)

 

 

 

SILICON LABORATORIES INC.

2009 STOCK INCENTIVE PLAN

 

SILICON LABORATORIES INC.

2009 EMPLOYEE STOCK PURCHASE PLAN

(Full Title of the Plans)

 

 

 

G. Tyson Tuttle

Chief Executive Officer

400 West Cesar Chavez

Austin, Texas 78701

(Name and Address of Agent for Service)

 

(512) 416-8500

(Telephone Number, Including Area Code, of Agent for Service)

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer x   Accelerated filer ¨
         
Non-accelerated filer ¨  (do not check if a small reporting company)   Smaller reporting company ¨
 
Emerging growth company ¨ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Exchange Act. ¨

 

 

CALCULATION OF REGISTRATION FEE

 

Title of Securities to be Registered

 

 

 

Amount to be
Registered
(1)

 

 

 

Proposed Maximum
Offering Price Per
Share

 

 

 

Proposed Maximum
Aggregate Offering Price

 

 

 

Amount of
Registration Fee

 

 

 

Common Stock, $0.0001 par value per
share to be issued under the 2009 Stock Incentive Plan

 

 

 

2,000,000(2)

 

 

 

$142.15

 

 

 

 

 

$284,300,000

 

 

 

 

$31,017.13(3)

 

 

Common Stock, $0.0001 par value per
share to be issued under the 2009
Employee Stock Purchase Plan

 

 

 

800,000(4)

 

 

 

$120.83

 

 

 

 

$96,664,000 

 

 

 

 

$10,546.05(5)

 

 

 TOTAL:  

 

 

2,800,000

 

 

 

 

 

 

 

 

 

 

$380,964,000

 

 

 

 

$41,563.18

 

 

 

 

(1)

 

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) shall also cover any additional shares of Common Stock, par value $0.0001 per share (the “Common Stock”), of Silicon Laboratories Inc. (the “Registrant”) which become issuable under the Silicon Laboratories Inc. 2009 Stock Incentive Plan (the “2009 Stock Plan”) and the Silicon Laboratories Inc. 2009 Employee Stock Purchase Plan (the “2009 ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of outstanding shares of the Registrant’s Common Stock.
   

(2)

 

The shares registered herein represent additional shares of the Registrant’s Common Stock reserved under an amendment and restatement of the 2009 Stock Plan approved by the Registrant’s stockholders at the Registrant’s annual meeting on April 22, 2021. Shares previously reserved under such plan were registered on Form S-8 on July 26, 2017, Form S-8 on April 29, 2014 and Form S-8 on May 1, 2009.
   

(3)

 

Estimated in accordance with Rule 457(c) and Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee of the additional shares of the Registrant’s Common Stock reserved for future issuance under the 2009 Stock Plan. The computation is based on the average of the high and low prices of the Registrant’s Common Stock as reported on NASDAQ Global Select Market on April 30, 2021.
   

(4)

 

 The shares registered herein represent additional shares of the Registrant’s Common Stock reserved under an amendment and restatement of the 2009 ESPP approved by the Registrant’s stockholders at the Registrant’s annual meeting on April 22, 2021. Shares previously reserved under such plan were registered on Form S-8 on July 26, 2017, Form S-8 on April 29, 2014 and Form S-8 on May 1, 2009.
   

(5)

 

Estimated in accordance with Rule 457(c) and Rule 457(h) under the Securities Act solely for the purposes of calculating the registration fee of the additional shares of the Registrant’s Common Stock reserved for future issuance under the 2009 ESPP. The computation is based on 85% of the average of the high and low prices of the Registrant’s Common Stock as reported on NASDAQ Global Select Market on April 30, 2021. Pursuant to the 2009 ESPP, the purchase price of a share of the Registrant’s Common Stock is 85% of the fair market value of the Common Stock.

 

 

 

 

 

PART I

 

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

The documents containing the information specified in Part I of this Registration Statement on Form S-8 (this “Registration Statement”) will be delivered or made available to participants as specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the “Securities Act”). Such documents need not be filed with the Securities and Exchange Commission (the “Commission”) either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 of the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 (Part II of this Registration Statement), taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

 

I-1

 

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

The following documents filed by Silicon Laboratories Inc. (the “Registrant”) with the Commission are incorporated by reference into this Registration Statement:

 

(a) The Registrant’s Annual Report on Form 10-K for the fiscal year ended January 2, 2021, filed with the Commission on February 3, 2021;

 

(b) All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) since the end of the fiscal year covered by the Registrant’s latest Annual Report referred to in (a) above, provided that any portions of such reports that are deemed furnished and not filed shall not be incorporated by reference into this Registration Statement; and

 

(c) The description of the Registrant’s Common Stock which is contained in its Registration Statement (SEC File No. 000-29823) on Form 8-A filed with the Commission on March 7, 2000 pursuant to Section 12 of the Exchange Act, including any amendment or report filed for the purpose of updating such description.

 

In addition, all documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement, and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents.

 

Item 4. Description of Securities.

 

Not applicable.

 

Item 5. Interests of Named Experts and Counsel.

 

Not applicable.

 

Item 6. Indemnification of Directors and Officers.

 

Section 145 of the Delaware General Corporation Law (the “DGCL”) provides, in effect, that any person made a party to any action by reason of the fact that he is or was a director, officer, employee or agent of the Registrant may and, in some cases, must be indemnified by the Registrant against, in the case of a non-derivative action, judgments, fines, amounts paid in settlement and reasonable expenses (including attorneys’ fees) incurred by him as a result of such action, and in the case of a derivative action, against expenses (including attorneys’ fees), if in either type of action he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Registrant. This indemnification does not apply, in a derivative action, to matters as to which it is adjudged that the director, officer, employee or agent is liable to the Registrant, unless upon court order it is determined that, despite such adjudication of liability, but in view of all the circumstances of the case, he is fairly and reasonably entitled to indemnity for expenses, and, in a non-derivative action, to any criminal proceeding in which such person had no reasonable cause to believe his conduct was unlawful.

 

The Registrant’s certificate of incorporation provides that no director shall be liable to the Registrant or its stockholders for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by the DGCL. The Registrant’s bylaws require it to indemnify its directors and executive officers to the fullest extent permitted by Delaware law. The Registrant has entered into indemnification agreements with all of its directors and executive officers and has purchased directors’ and officers’ liability insurance.

 

II-1

 

Item 7. Exemption From Registration Claimed.

 

Not applicable.

 

Item 8. Exhibits.

 

Exhibit
Number
    Description
    4.1       Fourth Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Registration Statement on Form S-1 (SEC File No. 333-94853))
       
    4.2       Fifth Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 3, 2021)
       
    4.3*     Silicon Laboratories Inc. 2009 Stock Incentive Plan (As Amended and Restated on April 22, 2021)
       
    4.4*       Silicon Laboratories Inc. 2009 Employee Stock Purchase Plan (As Amended and Restated on April 22, 2021)
       
    5.1*       Opinion of DLA Piper LLP (US)
       
    23.1*       Consent of DLA Piper LLP (US) (included in Exhibit 5.1)
       
    23.2*       Consent of Independent Registered Public Accounting Firm
       
    24.1*     Power of Attorney (included within signature page to this Registration Statement)

 

 

* Filed herewith.

 

II-2

 

Item 9. Undertakings.

 

(A) The undersigned Registrant hereby undertakes:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

 

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

 

(ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement;

 

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

 

Provided, however, that paragraphs (1)(i) and (1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

 

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(B) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(C) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

II-3

 

 SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant, Silicon Laboratories Inc., certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Austin, State of Texas, on May 5, 2021.

 

    SILICON LABORATORIES INC.
     
    By: /s/ G. Tyson Tuttle
      G. Tyson Tuttle
      Chief Executive Officer and Director

 

POWER OF ATTORNEY

 

Each person whose signature appears below constitutes and appoints G. Tyson Tuttle and John C. Hollister, and each of them, acting individually, as his or her attorney-in-fact, each with the power of substitution, for him in any and all capacities, to sign any amendment to this Registration Statement and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorneys-in-fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming the said attorney-in-fact or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature     Capacity     Date  
         
/s/ NAVDEEP S. SOOCH     Chairman of the Board     May 5, 2021      
Navdeep S. Sooch         
         
/s/ G. TYSON TUTTLE     Chief Executive Officer and Director (Principal Executive Officer)      May 5, 2021    
G. Tyson Tuttle         
         
/s/ JOHN C. HOLLISTER     Senior Vice President and Chief Financial Officer (Principal Financial Officer)     May 5, 2021  
John C. Hollister         
         
/s/ WILLIAM G. BOCK     Director     May 5, 2021        
William G. Bock          

 

II-4

 

         
/s/ JACK R. LAZAR       Director       May 5, 2021  
Jack R. Lazar           
                   
/s/ GREGG LOWE       Director       May 5, 2021  
Gregg Lowe           
                   
/s/ NINA RICHARDSON       Director       May 5, 2021  
Nina Richardson           
                   
/s/ SUMIT SADANA       Director         May 5, 2021    
Sumit Sadana          
         
/s/ WILLIAM WOOD     Director         May 5, 2021    
William Wood          
         
  /s/ CHRISTY WYATT     Director   May 5, 2021  
Christy Wyatt                

 

II-5